Martin Elišák

476 total citations
15 papers, 142 citations indexed

About

Martin Elišák is a scholar working on Neurology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Martin Elišák has authored 15 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 4 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in Martin Elišák's work include Autoimmune Neurological Disorders and Treatments (8 papers), Peripheral Neuropathies and Disorders (7 papers) and Multiple Sclerosis Research Studies (4 papers). Martin Elišák is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (8 papers), Peripheral Neuropathies and Disorders (7 papers) and Multiple Sclerosis Research Studies (4 papers). Martin Elišák collaborates with scholars based in Czechia, Sweden and Germany. Martin Elišák's co-authors include Petr Marusič, Vladimı́r Komárek, Anna Šedivá, Jana Kayserová, Frank Leypoldt, Kamila Volna, David Krýsl, Christian G. Bien, Eva Meluzínová and Klaus‐Peter Wandinger and has published in prestigious journals such as PLoS ONE, Journal of Neuroinflammation and Multiple Sclerosis Journal.

In The Last Decade

Martin Elišák

8 papers receiving 136 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Elišák Czechia 4 122 25 25 24 21 15 142
Corinna Bien Germany 10 245 2.0× 42 1.7× 41 1.6× 48 2.0× 15 0.7× 16 270
Marie Bénaiteau France 6 86 0.7× 18 0.7× 17 0.7× 15 0.6× 31 1.5× 24 140
Amber Stocco United States 3 196 1.6× 15 0.6× 58 2.3× 33 1.4× 23 1.1× 5 209
Jonas Leubner Germany 5 79 0.6× 28 1.1× 29 1.2× 13 0.5× 5 0.2× 9 111
Ana Felipe‐Rucián Spain 5 226 1.9× 69 2.8× 54 2.2× 51 2.1× 25 1.2× 15 290
Brigitte Wildemann Germany 5 141 1.2× 60 2.4× 16 0.6× 18 0.8× 5 0.2× 7 176
Deepti Pilli Australia 4 52 0.4× 23 0.9× 8 0.3× 10 0.4× 5 0.2× 5 95
Mariska M.P. Nagtzaam Netherlands 5 342 2.8× 60 2.4× 72 2.9× 52 2.2× 29 1.4× 5 351
Stephanie B. Conant United States 6 62 0.5× 44 1.8× 10 0.4× 32 1.3× 3 0.1× 6 218
Matthias Eckenweiler Germany 7 32 0.3× 51 2.0× 12 0.5× 7 0.3× 6 0.3× 22 126

Countries citing papers authored by Martin Elišák

Since Specialization
Citations

This map shows the geographic impact of Martin Elišák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Elišák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Elišák more than expected).

Fields of papers citing papers by Martin Elišák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Elišák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Elišák. The network helps show where Martin Elišák may publish in the future.

Co-authorship network of co-authors of Martin Elišák

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Elišák. A scholar is included among the top collaborators of Martin Elišák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Elišák. Martin Elišák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Elišák, Martin, et al.. (2025). Elevated serum neurofilament light chain levels in patients with neuropsychiatric systemic lupus erythematosus: a cross-sectional study. Lupus Science & Medicine. 12(1). e001309–e001309. 2 indexed citations
2.
Dargvainiene, Justina, et al.. (2023). Antibody-Negative Autoimmune Encephalitis. Neurology Neuroimmunology & Neuroinflammation. 10(6). 8 indexed citations
3.
Elišák, Martin, et al.. (2023). Laboratory biomarkers - neural antibodies in autoimmune diseases of the central nervous system. Neurologie pro praxi. 24(3). 200–205.
4.
Elišák, Martin, et al.. (2023). Paraneoplastic or not? Sirtuin 2 in anti‐N‐methyl‐d‐aspartate receptor encephalitis. European Journal of Neurology. 30(10). 3228–3235. 1 indexed citations
5.
Meluzínová, Eva, et al.. (2022). IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis. PLoS ONE. 17(6). e0270607–e0270607. 12 indexed citations
6.
Elišák, Martin. (2022). Ocrelizumab - long-term efficacy and safety in real-world clinical practice in patients with relapsing-remitting multiple sclerosis. Neurologie pro praxi. 23(3). 233–237. 1 indexed citations
7.
Meluzínová, Eva, et al.. (2020). Effectiveness of natalizumab extended interval dosing in multiple sclerosis patients. Česká a slovenská neurologie a neurochirurgie. 83/116(1). 79–83.
8.
Meluzínová, Eva, et al.. (2020). Elevated D-dimer as an immediate response to alemtuzumab treatment. Multiple Sclerosis Journal. 27(1). 151–154. 3 indexed citations
9.
Elišák, Martin, et al.. (2020). Autoimmune encephalitis with negative anti-neuronal antibodies – clinical characteristics and available methods of antibody detection. Česká a slovenská neurologie a neurochirurgie. 83/116(3). 251–256. 1 indexed citations
10.
Elišák, Martin, David Krýsl, Kamila Volna, et al.. (2018). The prevalence of neural antibodies in temporal lobe epilepsy and the clinical characteristics of seropositive patients. Seizure. 63. 1–6. 30 indexed citations
11.
Elišák, Martin, Eva Meluzínová, Petra Lišková, et al.. (2017). Anti-NMDAR Antibodies in Demyelinating Diseases. Česká a slovenská neurologie a neurochirurgie. 80/113(3). 332–335.
12.
Kayserová, Jana, et al.. (2016). Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid. Journal of Neuroinflammation. 13(1). 55–55. 81 indexed citations
13.
Elišák, Martin & Petr Marusič. (2015). Kdy v klinické praxi myslet na vzácná autoimunitní onemocnění centrálního nervového systému. Neurologie pro praxi. 16(6). 340–344.
14.
Elišák, Martin, et al.. (2015). Autoimmune Encephalitis. Česká a slovenská neurologie a neurochirurgie. 78/111(1). 7–23. 2 indexed citations
15.
Elišák, Martin, Jana Amlerová, Hana Krijtová, Martin Tomášek, & Petr Marusič. (2013). Temporal lobe epilepsy and hypermotor seizures. Epilepsy & Behavior. 28(2). 328–328. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Corinna Bien Breakdown of academic impact, for papers by Marie Bénaiteau Breakdown of academic impact, for papers by Amber Stocco Breakdown of academic impact, for papers by Jonas Leubner Breakdown of academic impact, for papers by Ana Felipe‐Rucián Breakdown of academic impact, for papers by Brigitte Wildemann Breakdown of academic impact, for papers by Deepti Pilli Breakdown of academic impact, for papers by Mariska M.P. Nagtzaam Breakdown of academic impact, for papers by Stephanie B. Conant Breakdown of academic impact, for papers by Matthias Eckenweiler
Rankless by CCL
2026